Introduction
The transcription factor PEBP2/CBF was originally identi®ed as an element that bound to the enhancers of murine polyomavirus and leukemia virus, and was subsequently shown to be a heterodimer composed of a and b subunits. (Kamachi et al., 1990; Ogawa et al., 1993a,b; Wang and Speck, 1992; Wang et al., 1993) . The Runt domain, which is conserved among the a subunit-encoding genes, is responsible for DNA binding activity and heterodimer formation with the b polypeptide Kagoshima et al., 1993; Meyers et al., 1993; Ogawa et al., 1993b) . On the other hand, the b subunit dimerizes with the a subunit to enhance its DNA binding anity, but does not show any intrinsic DNA-binding activity by itself (Ogawa et al., 1993a; Wang et al., 1993) . Of pathological importance is the fact that both the a subunitencoding Aml1/Pebpa2b/Cbfa2 and the b subunitencoding Pebpb2/Cbfb are protooncogenes involved in human acute myeloid and/or lymphoblastic leukemia (Erickson et al., 1992; Golub et al., 1995; Liu et al., 1993; Mitani et al., 1994; Miyoshi et al., 1991; Nucifora et al., 1993; Nucifora and Rowley, 1995; Romana et al., 1995; Shurtle et al., 1995) . The genes are located at the breakpoints in several types of chromosomal translocations and/or inversion associated with these leukemia. The notion that the a and b subunits function together in vivo as a complex termed PEBP2/CBF has been demonstrated in a remarkable way by recent gene targeting studies. Targeting of Pebpb2/Cbfb showed that this gene is essential for the development of de®nitive hematopoiesis in the murine fetal liver (Sasaki et al., 1996; Wang et al., 1996b; Niki et al., 1997) . The Pebpb2/Cbfb (7/ 7) embryos did not develop the multipotent hematopoietic progenitors in the liver and died on embryonic day 12.5 probably as a result of hemorrhaging into the central nervous system. An almost identical phenotype was observed after the targeting of Aml1/Pebpa2b/ Cbfa2 (Okuda et al., 1996; Wang et al., 1996a) .
A prerequisite for PEBP2/CBF to function as a transcription factor is its location in the nucleus. As far as the expression and localization of the PEBP2b/ CBFb polypeptide are concerned, there are, however, several unexpected observations from the fact that PEBP2b/CBFb is a subunit of a transcription factor. The ®rst of these was our report dealing with the subcellular localization of the a and b proteins as examined by immunochemical staining of c-DNA transfected NIH3T3 cells (Lu et al., 1995) . In such cells, the a protein alone was found to be localized in the nucleus, whereas the b protein alone was localized in the cytoplasm. Only when the b was coexpressed with a truncated form of the a protein, did the b subunit become detectable in the nucleus. Secondly, we recently observed by immunohistochemistry that the PEBP2b/CBFb was expressed in a dierentiation dependent manner in the skeletal myogenic cells of murine embryos, and that the protein mainly accumulated in the cytoplasm (Chiba et al., 1997) . Only during a limited stage of dierentiation, namely in the multinucleated myotubes, was nuclear staining observed for PEBP2b/CBFb. These two observations, therefore, indicate that the localization of PEBP2b/ CBFb can be just as well cytoplasmic as nuclear.
One of the interesting aspects of the cytoplasmic PEBP2b/CBFb is our immunohistochemical observation that the protein was colocalized with the a-actinin on the Z-lines or their vicinity in the established skeletal muscle ®bers (Chiba et al., 1997) . This observation suggests an anity of PEBP2b/CBFb with cytoskeletal structures. In the present study, we have examined such a possibility using tissue culture cells. We demonstrate that the cytoplasmic PEBP2b/CBFb is in a form that is free from the a subunit, and that a part of this form is retained in the cytoskeleton preparation after detergent extraction of the cells and colocalizes with stress ®bers.
Results
Colocalization of PEBP2b/CBFb with stress ®bers on the cytoskeleton preparation A monolayer culture of REF52 cells was treated gently with 0.1% Nonidet P-40 (NP-40) in a microtubule stabilizing buer and fractionated into soluble and cytoskeleton preparations. The amounts of proteins from each fraction which corresponded to the equivalent cell number were separated by SDSpolyacrylamide gel electrophoresis (PAGE) and blotted onto a membrane. The ®lter was probed with anti-b peptide antibody (Figure 1 ) whose preparation and speci®city were described previously (Chiba et al., 1997) . As seen in lane 4, a signi®cant proportion of the 22 kilodaltons PEBP2b/CBFb protein which were expressed endogenously in the cells was found to be retained in the cytoskeleton fraction. On the other hand, only a relatively small amount of the protein was released into the soluble fraction (lane 2). Retention of PEBP2b/CBFb in the cytoskeleton preparation was also observed for the protein expressed exogenously from the transfected c-DNA (compare lanes 3 and 5). Thus, the immunoblot data indicate that a considerable proportion of PEBP2b/ CBFb, irrespective of whether it was expressed endogenously or from the transfected c-DNA, is retained on cytoskeletal structures. The extraction procedure used above was con®rmed to be adequate, since most of the lactate dehydrogenase molecules was recovered in the soluble fraction, whereas most of the actin molecules was retained in the cytoskeleton fraction as revealed by an immunoblot analysis using respective antibodies (data not shown).
We next examined the morphological distribution of PEBP2b/CBFb on the cytoskeleton preparation by immunocytochemistry. REF52 cells transfected by the Pebpb2/Cbfb cDNA were extracted with detergent as described above, ®xed and processed for double immuno¯uorescent staining (Figure 2 ). PEBP2b/CBFb was detected by the anti-peptide antibody followed by the¯uorescein-isothiocyanate (FITC) conjugated secondary antibody (Figure 2a ), whereas F-actin was detected by rhodamine-isothiocyanate (RITC) conjugated phalloidin (Figure 2b ). The samples were viewed through a confocal laser scanning microscope. Figure  2c is a superimposed image where a yellow color signi®es colocalization of¯uorescence from FITC and RITC. PEBP2b/CBFb was retained in the cytoskeleton preparation and showed some degree of colocalization with F-actin containing stress ®bers (examples are indicated by arrowheads). In the above experiments, speci®city of the PEBP2b/CBFb staining was con®rmed by preabsorption of the antibody with the peptide (data not shown).
Stress ®bers that run in parallel with the longuitudinal axis of the cell, on reaching the cell periphery, lodge into the cell membrane via molecules including the vinculin (Burridge et al., 1988; Geiger, 1979 Geiger, , 1989 . Double labelling was performed as above except that the anti-vinculin antibody was used instead of phalloidin. Figure 2d shows staining for PEBP2b/ CBFb, whereas the staining in Figure 2e represents vinculin. As seen in the superimposed image in Figure  2f , PEBP2b/CBFb colocalized in some degree with the vinculin in membrane processes.
To exclude a possibility of an artifact caused by a detergent extraction procedure, the c-DNA transfected REF52 cells were ®xed without detergent extraction and processed for double immuno¯uorescence as above. PEBP2b/CBFb again displayed colocalization with the F-actin on stress ®bers or with the vinculin in membrane processes (data not shown).
Cytoplasmic PEBP2b/CBFb as a free form, away from the a subunit The PEBP2/CBF transcription factor is a heterodimer of the DNA-binding a protein and the non-DNA binding b protein (Kamachi et al., 1990) . It is reasonable to speculate that the b protein which was retained on the cytoskeleton preparation and colocalized with stress ®bers exists in a free form, away from the a protein. This possibility was examined by using the electrophoretic mobility shift assay (EMSA, Figure  3 ). NIH3T3 cells were used in this assay, since PEBP2/ CBF DNA binding activity has been characterized well in this cell line (Kamachi et al., 1990) . NIH3T3 cells were transfected by plasmids expressing individually the Runt domain of AML1/ PEBP2aB/CBFA2, b1, b2 or b3 isoforms of PEBP2b/ CBFb. The three isoforms of PEBP2b/CBFb are generated by an alternatively splicing mechanism of the transcripts and dier in their carboxy-terminal amino acid sequences (Ogawa et al., 1993a; Wang et al., 1993) . Whole-cell extracts were prepared and subjected to EMSA, using the PEBP2/CBF binding sequence as a probe (Figure 3a) . The cell extract receiving the backbone-vector yielded a band of endogenous PEBP2/CBF DNA binding activity (lanes 1 and 2) . This band represents the ab heterodimer. The extracts of the cells transfected by b1, b2 or b3 gave bands with the same mobility as endogenous PEBP2/CBF (lanes 5 through 10), indicating that overexpression of b proteins does not have any apparent eect on PEBP2/CBF site DNA binding activity. On the other hand, the extract of the cells transfected by the Runt domain yielded three distinct, new bands each of which corresponded to Runt alone, a Runt/b1 heterodimer and a Runt/b2 heterodimer, respectively (lanes 3, 4 and 11, see below for the identi®cation of the new protein/DNA complexes). The occurrence of the bands, Runt/b1 and Runt/b2, is compatible with the interpretation that at least some of the endogenous b protein exists in a free form, away from the a protein, and that this free fraction is recruited by the exogenously expressed Runt domain to generate a Runt/b heterodimer. Presence of a faint band corresponding to PEBP2/CBF in the Runt-transfected cells indicates that endogenous PEBP2/CBF remained intact under these conditions. The sequence speci®c DNA binding of all the detected protein/DNA complexes was con®rmed by a competition assay (Figure 3b ). The inclusion of an excessive amount of non-labeled wild type oligonucleotide abolished the mobility shift of the DNA bands, whereas mutated oligonucleotide had no eect.
To make sure that the new bands corresponded to Runt, Runt/b1 and Runt/b2 complexes, we mixed extracts in vitro and then subjected the mixtures to EMSA (Figure 3c ). The mixing of Runt-and vector alone-transfected cell extracts did not cause any essential change in the protein/DNA complexes (lane 2). On the other hand, when the extracts of Runt-and the extracts of b1-or b2-transfected cells were mixed, the DNA binding activities corresponding to putative Runt/b1 or Runt/b2 complexes were greatly enhanced (lanes 3 and 4). At the same time the band corresponding to the putative Runt domain-DNA complex disappeared. The result indicates that the exogenously expressed b1 or b2 proteins associate with the Runt domain to yield signi®cantly increased amounts of Runt/b1 or Runt/b2 heterodimers. A slight dierence in the mobilities of the Runt/b1 and Runt/b2 complexes in the EMSA is in agreement with the dierence between the calculated molecular masses of the b1 and b2 proteins (Ogawa et al., 1993a) . The mixing of the Runt domain extracts and b3 extracts did not cause any appreciable change (lane 5), in accordance with our previous report (Ogawa et al., 1993a) .
Finally, we quantitated the relative amounts of the endogenous PEBP2b/CBFb protein present in the cytoplasm or the nucleus of NIH3T3 cells by cell fractionation and immunoblot analysis. The cells were treated by 1% NP-40 and fractionated by centrifugation into cytoplasmic and nuclear fractions. The proteins from each fraction which corresponded to the same number of cells were separated by gel electrophoresis and the blotted ®lter was probed with the anti-b peptide antibody (Figure 4 ). As seen in lanes 2 and 3, most of the PEBP2b/CBFb protein was recovered in the cytoplasmic fraction. When NIH3T3 cells were immunocytochemically stained, most of the staining was detected in the cytoplasm as expected (data not shown). The data of immunoblot and immunocytochemistry thus demon- We must note that a PEBP2/CBF DNA binding activity was detected in non-transfected NIH3T3 cells (see lane 2 in Figure 3a) . Conceivably, an amount of b protein below a detectable level by immunological procedures could be associated with the a protein and be present as a heterodimer in the nucleus of NIH3T3 cells.
Discussion

PEBP2b/CBFb and cytoskeleton
In the present study we have shown that the endogenous PEBP2b/CBFb in the cell is mainly present in the cytoplasm. This cytoplasmic PEBP2b/ CBFb is most likely to be in a free form, separate from its partner, the a subunit, as judged by EMSA. Instead of interacting with the a protein, the cytoplasmic Figure 3 PEBP2/CBF site DNA binding activities in plasmids-transfected NIH3T3 cells detected by EMSA. NIH3T3 cells were either transfected with a plasmid expressing the Runt domain of AML1/PEBP2aB/CBFA2, or with plasmids that individually expressed the b1, b2 or b3 isoforms of PEBP2b/CBFb, as indicated. The cells were also transfected with a backbone plasmid harboring no cDNA sequence (in lanes indicated as a vector). Whole-cell extracts were prepared and subjected to EMSA. The amount of extracts corresponded to 2 mg protein in the lanes having odd numbers in (a) and lanes 4 through to 6 in (b). In the even numbered lanes of (a) and in the lanes 1 through to 3 of (b), 4 mg of protein was used. Lane 11 in (a) is a lightly exposed image of lane 4. In (b), a 100-fold molar excess of unlabeled wild type PEBP2/CBF site sequence (lanes 2 and 5) or mutated sequence (lanes 3 and 6) was included. In (c) 2 mg protein from the Runt domain-transfected cells was preincubated for 60 min on ice with 2 mg protein from either the vector alone, b1, b2 or b3 transfected cells and the mixture was then subjected to EMSA PEBP2b/CBFb was found to be retained in the cytoskeleton preparation and colocalize with the Factin on stress ®bers and the vinculin in membrane processes. The anity between PEBP2b/CBFb and the cytoskeleton appears relatively weak, however, since only a part of the PEBP2b/CBFb present in the cell colocalized with stress ®bers. Most of the b protein appeared as diuse staining in the cytoplasm. In addition, when the two c-DNAs were coexpressed, relocalization of the b protein to the nucleus in the presence of a truncated form of the a protein did not apparently aect the morphology of the cell or the stress ®bers (data not shown). Therefore, it seems unlikely that PEBP2b/CBFb is an authentic component that constitutes by itself part of the stress ®bers. Such a relatively weak anity may be related to the fact that a modest level of homology exists between PEBP2b/ CBFb and cytoskeletal proteins such as troponin T and non-muscle myosin heavy chain (data not shown).
Implication of the cytoskeleton-anitive PEBP2b/CBFb
What kind of a role can be inferred for the cytoskeleton-anitive PEBP2b/CBFb? The NFkB/IkB complex presents a somewhat analogous precedent that also involves translocation from the cytoskeleton to the nucleus. Under unstimulated conditions NFkB is retained in the cytoplasm as a complex with the inhibitor protein, IkB, which has an ankyryn repeat (Baeuerle and Baltimore, 1988) . Phosphorylation, ubiquitination and degradation of IkB results in NFkB release from this complex and translocation of NFkB into the nucleus (Palombella et al., 1994) . Another case is the glucocorticoid receptor which forms a complex with hsp70 and hsp90 and is located in the cytoplasm (see a review by Pratt, 1993) . The binding of the ligand to the receptor triggers the dissociation of the complex and releases the receptor from the hsp proteins, thus driving the receptor into the nucleus. In a fashion analogous to IkB or hsp proteins, the cytoskeleton in the cytoplasm may serve to anchor PEBP2b/CBFb. Thus, the PEBP2b/CBFb located on the cytoskeleton may act as a reservoir of free b before transportation into the nucleus as part of an ab heterodimer. On the other hand, the possibility cannot be excluded that PEBP2b/CBFb plays an yet unidentified role in the structure/function of cytoskeleton. A protein that shows the characteristics of both a cytoskeletal and transcriptional protein is b-catenin. On the one hand, b-catenin is a component of the adherens junction and links the cadherin membrane protein to the cytoskeleton (Aberle et al., 1994; HuÈ lsken et al., 1994; McCrea et al., 1991; Nagafuchi et al., 1994) . On the other hand, in the Wnt-signaling pathway, formation of a complex of cytoplasmic bcatenin with the lymphoid enhancer-binding factor 1 (LEF-1) results in the translocation of b-catenin into the nucleus where it alters the DNA bending activity of LEF-1 (Behrens et al., 1996; Huber et al., 1996) .
In inv 16(p13q22) which is involved in a subtype of human acute myeloid leukemia, the chimeric gene is generated between the Pebpb2/Cbfb and smooth muscle myosin heavy chain (SMMHC) genes (Liu et al., 1993) . It should be pointed out that the SMMHC portion in the chimeric product represents the rod domain of the myosin heavy chain molecule and that the chimeric protein, when expressed alone in the c-DNA transfected NIH3T3 cells, is located in the cytoplasm, as shown in our previous study (Lu et al., 1995) . In the case of chronic myeloid leukemia, BCR/ABL protein is associated with actin-micro®laments and is responsible for the enhanced phosphorylation of focal adhesion proteins (Salgia et al., 1995) . An extension of our present study on the cytoskeleton-anitive PEBP2b/CBFb to that on the PEBP2b/CBFb-SMMHC chimeric protein should increase our understanding of the molecular mechanisms of leukemogenesis caused by inv 16 (p13q22).
Materials and methods
Cell culture and c-DNA transfection NIH3T3 and REF52 cells were maintained in Dulbecco modi®ed Eagle medium supplemented with 10% (vol/vol) calf serum (NIH3T3) or fetal bovine serum (REF52). DNA transfection was performed by a calcium phosphate coprecipitation method, as modi®ed by Chen and Okayama (1987) . Four or twenty mg DNA was used for cells grown in 3-or 10 cm-diameter dishes. The expression plasmids were pEF-b1, pEF-b2, pEF-b3 and pCX2neoBS, all of which were previously described (Lu et al., 1995; Sakakura et al., 1994) . The former three plasmids express b1, b2 or b3 isoform of PEBP2b/CBFb, respectively, while pCX2neoBS harbors the Runt domain of AML1/ PEBP2aB/CBFA2 protein. Fifteen hours after seeding the cells were transfected with the c-DNA, incubated for a further 26 h and then processed for immunochemical analysis or EMSA.
The antibody
The anti-PEBP2b/CBFb peptide antibody was raised in hens as described previously (Chiba et al., 1997) . This antibody was puri®ed for immunocytochemical staining by anity chromatography on a column in which the peptide was linked to cyanogen bromide-activated Sepharose 4B (Pharmacia). In a preabsorption experiment, 100 ml of 100-fold-diluted, anity puri®ed anti-peptide antibody was incubated with 20 mg of the peptide on ice for 60 min prior to the use in immunodetection.
Preparation of the cytoplasmic and nuclear fractions NIH3T3 cells grown in 10 cm-diameter dishes at 1610 6 cells were rinsed twice in phosphate buered saline (PBS) and then scraped into 500 ml of a TNE buer containing 1% (vol/vol) NP-40. TNE was 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA and 0.01 mM phenylmethylsulfonyl¯uoride (PMSF). After centrifugation at 3000 r.p.m. for 5 min at 48C, the supernatant was taken to be the cytoplasmic fraction. The pellet was dissolved by rotating for 60 min at 48C in 500 ml of a RIPA buer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% 0.1% [wt/vol] sodium deoxycholate, 0.1% [wt/vol] SDS, 10 mg/ml of aprotinin, 2.5 mM dithiothreitol and 1 mM PMSF). After sonication and centrifugation at 15000 r.p.m. for 10 min at 48C, the supernatant was taken to be the nuclear fraction. The protein from each fraction was subjected to an immunoblot analysis.
Preparation of the cytoskeleton
REF52 cells grown in 10 cm-diameter dishes at 1610 6 cells were rinsed once with a microtuble stabilizing buer (MSB; 0.1 M piperazine-N,N'-bis [2-ethanesulfonic acid], pH 6.9, 2 M glycerol, 5 mM MgCl 2 and 2 mM EGTA). The cells were then covered gently with 500 ml of 0.1% (vol/vol) NP-40 in MSB and the solution was quickly recovered and taken to be the soluble fraction. The remaining material was scraped into a cold solution of 10% (wt/vol) trichloroacetic acid. The pellet recovered by centrifugation was dissolved in 210 ml of a buer containing 9 M urea, 2% (vol/vol) Triton X-100, 1% (wt/vol) dithiothreitol, 2% (wt/vol) lithium dodecylsulfate and 50 mM Tris-HCl, pH 7.5 and taken to be the cytoskeleton fraction. Protein concentrations were 0.39 mg/ml for the soluble and 0.94 mg/ ml for the cytoskeleton fraction, respectively. Therefore, the total yields from 1610 6 cells were 195 mg and 197 mg protein for each fraction. Twenty mg of the protein from each fraction which corresponded to the equivalent cell number (1610 5 ) was subjected to an immunoblot analysis. For immunocytochemical staining, REF52 cells grown on coverslips were treated with 0.1% (vol/vol) NP-40 in MSB as described above, ®xed with 3.7% (wt/vol) formaldehyde in PBS for 10 min and processed for immunostaining.
Western blot (immunoblot) analysis
The protein extract was precipitated by adding trichloroacetic acid to 10% (wt/vol) and the pellet was dissolved in an SDS ± PAGE sample buer. The proteins were separated by electrophoresis on a 0.1% (wt/vol) SDS ± 12% (wt/vol) polyacrylamide gel. The transfer of the proteins from the gel onto the ®lter, the blocking reaction, incubation of the ®lter with the appropriate antibodies and visualization of the immunocomplexes using ABC kit and ECL detection reagents were as described previously (Chiba et al., 1997) .
The primary antibody used was 1000-fold-diluted anti-b peptide chick IgY solution (11.3 mg/ml).
Immunocytochemistry
REF52 cells were seeded at 1610
5 cells per 3 cm-diameter dish, into which glass coverslips had already been placed. The cytoskeleton was prepared as above, ®xed with formaldehyde and processed for double immunofluorescent staining of PEBP2b/CBFb and F-actin. The primary antibody was the anity puri®ed anti-b peptide antibody (100-fold-diluted) and the secondary antibody was a mixture of FITC-conjugated goat antiserum against-chick IgY (100-fold-diluted, Bethyl) and 0.2 unit/ml of RITCconjugated phalloidin (Molecular Probes, Inc.). To label vinculin, 100-fold-diluted, mouse monoclonal antibody against vinculin (Biohit Oy) and 20-fold-diluted, RITCconjugated goat antiserum against mouse IgG (Organon Teknika Corp.) were used. Incubation of the samples with the respective antibodies was for 30 min at 378C and the samples were rinsed in PBS after each antibody incubation. Coverslips were mounted on glass slides with buered glycerol medium and the cells were viewed with a confocal laser scanning microscope (LSM410, Zeiss).
EMSA
Whole-cell extracts from 1610 6 of NIH3T3 cells in 10 cmdiameter dishes were prepared by the freeze-thaw method as previously described (Lu et al., 1995) . The cell pellets were suspended in 1 ml of a buer containing 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES]-KOH, pH 7.9, 400 mM NaCl, 25% (vol/vol) glycerol, 1 mM EDTA, 2.5 mM dithiothreitol and 1 mM PMSF, frozen and thawed three times. The supernatant after centrifugation at 13000 r.p.m. for 10 min was taken to be the extract. The extracts containing 2 or 4 mg of proteins was incubated in 12 ml of a buer containing 20 mM HEPES-KOH, pH 7.6, 4% (wt/vol) Ficoll, 50 mM KCl, 1.5 mg of poly (dI±dC), 2 mM EDTA, 1 mM dithiothreitol and the DNA probe (1 ng, 2.0610 5 c.p.m./pmole). The incubation was continued at room temperature for 30 min. Samples were analysed on 6% (wt/vol) nondenaturing polyacrylamide (60:1, acrylamide:bisacrylamide) gels. The DNA probe used was the polyomavirus enhancer sequence (5'-GATCCAACTGACCGCAGCTG-3') end labeled with [ 32 P] by the Klenow enzyme. The underlined sequence represents a PEBP2 binding site. A mutated version of the DNA probe harbored the sequence, 5'-GATCCAACT-GAACGAAGCTG-3', where the underlined residues represent the mutated locations.
